Immunoscore Combining CD8, FoxP3, and CD68-Positive Cells Density and Distribution Predicts the Prognosis of Head and Neck Cancer Patients.

Authors : Furgiuele S, Descamps G, Lechien JR, Dequanter D, Journe F, Saussez S
Year : 2022
Journal : Cells
Volume : 11

Cytokine Landscape in Central Nervous System Metastases.

Authors : Marin J, Journe F, Ghanem GE, Awada A, Kindt N
Year : 2022
Journal : Biomedicines
Volume : 10

Neutrophil-to-lymphocyte ratio as a prognostic marker for head and neck cancer with lung metastasis: a retrospective study.

Authors : Yanni A, Buset T, Bouland C, Loeb I, Lechien JR, Rodriguez A, Journe F, Saussez S, Dequanter D
Year : 2022
Journal : Eur Arch Otorhinolaryngol
Volume : 279
Pages : 4103-4111

Understanding Molecular Mechanisms of Phenotype Switching and Crosstalk with TME to Reveal New Vulnerabilities of Melanoma.

Authors : Najem A, Soumoy L, Sabbah M, Krayem M, Awada A, Journe F, Ghanem GE
Year : 2022
Journal : Cells
Volume : 11

Immune Cell Density Evaluation Improves the Prognostic Values of Staging and p16 in Oropharyngeal Cancer.

Authors : Descamps G, Furgiuele S, Mhaidly N, Journe F, Saussez S
Year : 2022
Journal : Cancers (Basel)
Volume : 14

Regorafenib Induces Senescence and Epithelial-Mesenchymal Transition in Colorectal Cancer to Promote Drug Resistance.

Authors : Kehagias P, Kindt N, Krayem M, Najem A, Agostini G, Acedo Reina E, Bregni G, Sclafani F, Journe F, Awada A, Ghanem GE, Hendlisz A
Year : 2022
Journal : Cells
Volume : 11

Bufalin for an innovative therapeutic approach against cancer.

Authors : Soumoy L, Ghanem GE, Saussez S, Journe F
Year : 2022
Journal : Pharmacol Res
Volume : 184
Pages : 106442

Dealing with Macrophage Plasticity to Address Therapeutic Challenges in Head and Neck Cancers.

Authors : Furgiuele S, Descamps G, Cascarano L, Boucq A, Dubois C, Journe F, Saussez S
Year : 2022
Journal : Int J Mol Sci
Volume : 23

Corrigendum to 'p53 Reactivation by PRIMA-1Met (APR-246) sensitises V600E/KBRAF melanoma to vemurafenib'[Eur J of Cancer 55 (2016) 98-110].

Authors : Krayem M, Journe F, Wiedig M, Morandini R, Najem A, Salès F, Van Kempen LC, Sibille C, Awada A, Marine JC, Ghanem G
Year : 2022
Journal : Eur J Cancer
Volume : 175
Pages : 336-338

Prognostic Significance of a Scoring System Combining p16, Smoking, and Drinking Status in a Series of 131 Patients with Oropharyngeal Cancers.

Authors : Bouland C, Dequanter D, Lechien JR, Hanssens C, de Saint-Aubain de Somerhausen N, Digonnet A, Javadian R, Yanni A, Rodriguez A, Loeb I, Journe F, Saussez S
Year : 2021
Journal : Int J Otolaryngol
Volume : 2021
Pages : 8020826

Apoptotic and Non-Apoptotic Modalities of Thymoquinone-Induced Lymphoma Cell Death: Highlight of the Role of Cytosolic Calcium and Necroptosis.

Authors : Berehab M, Rouas R, Akl H, Duvillier H, Journe F, Fayyad-Kazan H, Ghanem G, Bron D, Lewalle P, Merimi M
Year : 2021
Journal : Cancers (Basel)
Volume : 13

New Treatment Strategy Targeting Galectin-1 against Thyroid Cancer.

Authors : Gheysen L, Soumoy L, Trelcat A, Verset L, Journe F, Saussez S
Year : 2021
Journal : Cells
Volume : 10

Effect of Oxidized Low-Density Lipoprotein on Head and Neck Squamous Cell Carcinomas.

Authors : Kindt N, Journe F, Carlier S, Trelcat A, Scalia A, Saussez S
Year : 2021
Journal : Biomedicines
Volume : 9

Survival and treatment outcome of head and neck cancer patients with pulmonary oligometastases.

Authors : Lardinois I, Dequanter D, Lechien JR, Bouland C, Javadian R, Rodriguez A, Loeb I, Journe F, Saussez S
Year : 2021
Journal : Clin Otolaryngol
Volume : 46
Pages : 311-317

RTK Inhibitors in Melanoma: From Bench to Bedside.

Authors : Sabbah M, Najem A, Krayem M, Awada A, Journe F, Ghanem G
Year : 2021
Journal : Cancers (Basel)
Volume : 13

Dasatinib Stimulates Its Own Mechanism of Resistance by Activating a CRTC3/MITF/Bcl-2 Pathway in Melanoma with Mutant or Amplified c-Kit.

Authors : Sabbah M, Krayem M, Najem A, Sales F, Miller W, Del Rincon S, Awada A, Ghanem GE, Journe F
Year : 2021
Journal : Mol Cancer Res
Volume : 19
Pages : 1221-1233

Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates anti-tumor immune responses.

Authors : Huang F, Goncalves C, Bartish M, Rémy-Sarrazin J, Issa ME, Cordeiro B, Guo Q, Emond A, Attias M, Yang W, Plourde D, Su J, Gimeno MG, Zhan Y, Galán A, Rzymski T, Mazan M, Masiejczyk M, Faber J, Khoury E, Benoit A, Gagnon N, Dankort D, Journe F, Ghanem G, Krawczyk CM, Saragovi HU, Piccirillo CA, Sonenberg N, Topisirovic I, Rudd CE, Miller WH Jr, Del Rincón SV
Year : 2021
Journal : J Clin Invest

Tyrosine-Dependent Phenotype Switching Occurs Early in Many Primary Melanoma Cultures Limiting Their Translational Value.

Authors : Najem A, Wouters J, Krayem M, Rambow F, Sabbah M, Sales F, Awada A, Aerts S, Journe F, Marine JC, Ghanem GE
Year : 2021
Journal : Front Oncol
Volume : 11
Pages : 780654

Restoring p53 Function in Head and Neck Squamous Cell Carcinoma to Improve Treatments.

Authors : de Bakker T, Journe F, Descamps G, Saussez S, Dragan T, Ghanem G, Krayem M, Van Gestel D
Year : 2021
Journal : Front Oncol
Volume : 11
Pages : 799993

Severity of Anosmia as an Early Symptom of COVID-19 Infection May Predict Lasting Loss of Smell.

Authors : Lechien JR, Journe F, Hans S, Chiesa-Estomba CM, Mustin V, Beckers E, Vaira LA, De Riu G, Hopkins C, Saussez S
Year : 2020
Journal : Front Med (Lausanne)
Volume : 7
Pages : 582802